Nifty
Sensex
:
:
23907.25
79117.11
557.35 (2.39%)
1961.32 (2.54%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 538965 | NSE: Not Listed

35.97
22-Nov-2024
  • Open
  • High
  • Low
  • Previous Close
  •  36
  •  37.79
  •  35.8
  •  35.74
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  24101
  •  876440
  •  61.50
  •  30.59

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 35.74
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 54.78
  • N/A
  • 1.04

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 54.39%
  • 0.08%
  • 45.11%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 0.42%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.22
  • 1.31
  • -0.03

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.00
  • 3.47
  • 6.15

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.10
  • 16.77
  • -35.26

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 38.43
  • 38.43
  • 38.43

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.12
  • 1.12
  • 1.12

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.40
  • 13.40
  • 13.40

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
12.37
7.53
64.28%
11.69
8.98
30.18%
15.64
12.31
27.05%
12.78
13.53
-5.54%
Expenses
11.50
5.91
94.59%
10.86
7.52
44.41%
15.29
11.34
34.83%
12.15
12.08
0.58%
EBITDA
0.88
1.61
-45.34%
0.83
1.46
-43.15%
0.35
0.97
-63.92%
0.63
1.44
-56.25%
EBIDTM
7.07%
21.44%
7.12%
16.25%
2.25%
7.88%
4.93%
10.68%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.47
0.43
9.30%
0.45
0.44
2.27%
0.50
0.50
0.00%
0.50
0.45
11.11%
Depreciation
0.34
0.39
-12.82%
0.34
0.38
-10.53%
0.39
0.33
18.18%
0.39
0.38
2.63%
PBT
0.07
0.80
-91.25%
0.04
0.64
-93.75%
-0.55
0.14
-
-0.26
0.62
-
Tax
0.02
0.24
-91.67%
0.01
0.14
-92.86%
-0.21
-0.02
-
-0.02
0.16
-
PAT
0.04
0.56
-92.86%
0.03
0.49
-93.88%
-0.34
0.16
-
-0.24
0.45
-
PATM
0.35%
7.48%
0.22%
5.48%
-2.15%
1.33%
-1.88%
3.36%
EPS
0.04
0.60
-93.33%
0.03
0.53
-94.34%
-0.34
0.18
-
-0.24
0.52
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Net Sales
52.48
52.08
58.96
Net Sales Growth
23.92%
-11.67%
 
Cost Of Goods Sold
42.54
29.11
27.05
Gross Profit
9.94
22.96
31.91
GP Margin
18.94%
44.09%
54.12%
Total Expenditure
49.80
47.51
53.36
Power & Fuel Cost
-
0.00
0.00
% Of Sales
-
0%
0%
Employee Cost
-
3.84
4.14
% Of Sales
-
7.37%
7.02%
Manufacturing Exp.
-
12.65
15.68
% Of Sales
-
24.29%
26.59%
General & Admin Exp.
-
1.81
1.30
% Of Sales
-
3.48%
2.20%
Selling & Distn. Exp.
-
0.01
0.01
% Of Sales
-
0.02%
0.02%
Miscellaneous Exp.
-
0.08
5.19
% Of Sales
-
0.15%
8.80%
EBITDA
2.69
4.57
5.60
EBITDA Margin
5.13%
8.77%
9.50%
Other Income
0.00
0.01
0.10
Interest
1.92
1.71
1.68
Depreciation
1.46
1.63
1.76
PBT
-0.70
1.25
2.25
Tax
-0.20
0.26
0.65
Tax Rate
28.57%
20.80%
28.89%
PAT
-0.51
0.99
1.59
PAT before Minority Interest
-0.51
0.99
1.59
Minority Interest
0.00
0.00
0.00
PAT Margin
-0.97%
1.90%
2.70%
PAT Growth
-130.72%
-37.74%
 
EPS
-0.51
0.99
1.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Shareholder's Funds
31.70
28.36
Share Capital
9.32
8.74
Total Reserves
21.82
19.62
Non-Current Liabilities
4.91
4.44
Secured Loans
1.91
1.69
Unsecured Loans
0.00
0.00
Long Term Provisions
2.46
2.08
Current Liabilities
21.61
23.65
Trade Payables
5.27
7.18
Other Current Liabilities
1.74
1.85
Short Term Borrowings
14.23
13.95
Short Term Provisions
0.38
0.67
Total Liabilities
58.22
56.45
Net Block
12.28
13.33
Gross Block
37.08
36.50
Accumulated Depreciation
24.80
23.17
Non Current Assets
14.77
14.55
Capital Work in Progress
0.92
0.55
Non Current Investment
0.89
0.00
Long Term Loans & Adv.
0.04
0.03
Other Non Current Assets
0.00
0.00
Current Assets
43.46
41.89
Current Investments
0.00
0.00
Inventories
20.06
17.49
Sundry Debtors
15.81
22.86
Cash & Bank
0.10
0.07
Other Current Assets
7.48
0.27
Short Term Loans & Adv.
7.43
1.21
Net Current Assets
21.84
18.24
Total Assets
58.23
56.44

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Cash From Operating Activity
1.66
0.77
PBT
1.25
2.25
Adjustment
3.26
3.17
Changes in Working Capital
-2.46
-3.97
Cash after chg. in Working capital
2.04
1.45
Interest Paid
0.00
0.00
Tax Paid
-0.38
-0.67
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
-2.27
-2.44
Net Fixed Assets
-0.86
Net Investments
-1.42
Others
0.01
Cash from Financing Activity
0.62
1.68
Net Cash Inflow / Outflow
0.02
0.01
Opening Cash & Equivalents
0.06
0.04
Closing Cash & Equivalent
0.08
0.04

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Book Value (Rs.)
33.43
32.44
ROA
1.72%
2.82%
ROE
3.31%
5.62%
ROCE
6.32%
8.77%
Fixed Asset Turnover
1.42
1.62
Receivable days
135.50
141.52
Inventory Days
131.60
108.28
Payable days
78.03
96.87
Cash Conversion Cycle
189.07
152.93
Total Debt/Equity
0.54
0.58
Interest Cover
1.73
2.34

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.